Medicines Evaluation Board

Medicines Evaluation Board

Open Access statistics for Medicines Evaluation Board, Netherlands, covering academic research published from 2000 to 2023.

Open Access statistics for Medicines Evaluation Board, Netherlands, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

746


Total Open
Publications

481


Total
Citations

18K


Open Access
Percentage

64%


Total
Publications

746


Total Open
Publications

481


Total
Citations

18K

Website

download

Breakdown

11% 42% 12% 35%

Publisher Open

11%

Both

42%

Other Platform Open

12%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

107

Hybrid 48%

191

No Guarantees 25%

97

Other Platform Open

Institution 73%

291

Domain 63%

249

Other Internet 10%

38

Public 5%

18

Preprint 3%

11

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
250
Europe PMC
Domain
151
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
147
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
131
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Other Internet
73
Radboud University - Radboud Repository
Institution
64
Erasmus University Rotterdam - EUR Research Repository
Institution
54
Leiden University - Leiden Repository
Institution
16
Utrecht University - Utrecht University Repository
Institution
14
Semantic Scholar
Public
13
1 / 9

Data updated 17 June 2024

Share

Share

Share